Breast Cancer Update 2018: Management and Treatment (RP1809C)

September 21, 2018

The Breast Program Leadership Committee wants to provide the opportunity to share new innovations in breast care to all staff. The multidisciplinary care at the Harold C. Simmons Comprehensive Cancer Center are organized by disease-oriented teams (DOT). Most staff members, including the breast DOT, may not be aware of the new technologies and treatment plans available for breast patients. The purpose of this educational event is to present new innovations in the disciplines of surgical oncology, medical oncology, radiation oncology, genetics, plastic surgery, and imaging.

Target Audience

This activity is intended for providers in the specialties of: 

  • Oncology (Medical)
  • Pathology
  • Plastic Surgery
  • Radiology
  • Surgery - Oncology

Learning Objectives

Upon completion of this activity, participants should be able to:

    • Recognize the significance of breast cancer stage as an approximation of prognosis/survival.
    • Identify molecular subtypes and their significance in the new integrated AJCC 8th edition staging manual.
    • Explain the importance of regional lymph node staging using imaging techniques and the overall accuracy of each imaging modality.
    • Review the imaging modalities available to help correctly determine the true extent of disease in women with dense tissue who have been recently diagnosed with breast cancer.
    • Describe updated therapeutic guidelines as well as information regarding ongoing clinical trials regarding breast and axillary nodal surgery in breast cancer patients.
    • To describe use of Gamma Pod partial breast irradiation, including patient selection, logistics of treatment and patient experience with this technique.
    • Review current NCCN management recommendations for patients with breast cancer gene mutations.
    • Identify new methods in Implant based reconstruction and techniques and outcomes
    • Evaluate challenges in Implant based reconstruction.
    • Review new trial data supporting the use and effectiveness of decrease chemotherapy and HER2 therapy in adjuvant treatment.
    Course summary
    Available credit: 
    • 2.00 AMA
    • 2.00 Attendance
    Course opens: 
    09/13/2018
    Course expires: 
    09/20/2019
    Event starts: 
    09/21/2018 - 7:00am CDT
    Event ends: 
    09/21/2018 - 9:00am CDT
    Cost:
    $0.00
    Rating: 
    0

    Time

    Topic

    Presenter

    06:30 – 07:00

    Registration, Continental breakfast

    Introductions

    Dr. Phil Evans

    07:00-07:15

    A New Breast Cancer Staging Paradigm

    Dr. Basak Dogan

    07:15-07:30

    Evaluating Extent of Disease in Women with Dense Breasts

    Dr. Stephen Seiler

    07:30-07:45

    Less is More in Breast Cancer Surgery

    Dr. Rachel Wooldridge

    07:45-08:00

    Systemic Breast Cancer Treatment: the drive to deceleration.

    Dr. Barbara Haley

    08:00-08:15

    GammaPod – A New Innovation in Partial Breast Radiation Therapy

    Dr. Ann Spangler

    08:15-08:30

    Update on Breast Cancer Gene Mutations

    Caitlin Mauer

    08:30-08:45

    New Frontiers in Breast Reconstruction: Implant and Autologous reconstruction

    Dr. Sumeet Teotia

    Wrap-Up

    08:45-09:00

    Discussion,  Disclosures Evaluations,

    Dr. Phil Evans

    NB2.100A & NB2 EEF - UTSW - North Campus
    United States

    Course Director:

    W. Phil Evans, M.D., FACR, FSBI
    Clinical Professor and Division Chief, Breast Imaging
    George and Carol Poston Professorship in Breast Cancer Research
    Director, UT Southwestern Center for Breast Care

    Course Director(s)

    Walter Evans, M.D.

    has no relevant financial relationships to disclose at this time.
    Moderator(s)

    Walter Evans, M.D.

    has no relevant financial relationships to disclose at this time.

    The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation Statement

    The University of Texas Southwestern Medical Center designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Available Credit

    • 2.00 AMA
    • 2.00 Attendance

    Price

    Cost:
    $0.00
    Please login or create an account to take this course.